New! Targeted Therapy for Advanced Renal Cell Carcinoma: New Options, New Decisions
CNE Credits: 1.5
Planned and produced by the Oncology Nursing Society and funded by an educational grant from Wyeth Pharmaceuticals.

This interactive satellite symposium provides an evidence-based discussion of advanced renal cell carcinoma (RCC), including treatment and symptom management strategies. Expert faculty will provide an illustrated explanation of cellular changes, a clinical review of promising new treatments, and a comprehensive discussion of side effects and their management. Participants will use patient case studies to apply proven strategies to successfully manage the side effects of targeted therapies for RCC. View the webcast and take the CNE test.

Signal Transduction Pathways: Signposts to Improved Therapy for Advanced Renal Cell Carcinoma

This session provides an evidence-based discussion of advanced renal cell carcinoma (RCC), including treatment and symptom management strategies. Case discussion will give participants an opportunity to provide suggestions for assessment and interventions and to demonstrate their understanding of the implications. Learn more.

Advanced Renal Cell Carcinoma
Supported by an educational grant from Wyeth Pharmaceuticals to the Oncology Nursing Society.

This Advanced Renal Cell Carcinoma webcast was recorded from a satellite symposium at the Oncology Nursing Society's (ONS) 32nd Annual Congress, April 24-27, 2007, in Las Vegas, Nevada. This webcast will provide an evidence-based discussion of advanced renal cell carcinoma (RCC) including treatment and symptom management strategies. Case discussion will give participants an opportunity to provide suggestions for assessment and interventions and to demonstrate their understanding of the implications.

Goal
The goal of this program is to provide an evidence-based discussion of advanced renal cell carcinoma, including treatment and symptom management strategies.

Program Objectives
At the end of this webcast, the participant will be able to:

1. Differentiate between the mechanisms of action for cytokine therapy and agents that disrupt the VHL and mTor pathways when treating RCC.
2. Summarize the challenges treating and establishing improved survival rates related to RCC.
3. Summarize administration considerations for VHL and mTor pathway inhibitors.
4. List strategies to manage adverse events related to targeted therapies in treating RCC.

View Webcast | Take CNE Test

Renal Cell Cancer Toolkit
Supported by an educational grant from Wyeth Pharmaceuticals to the Oncology Nursing Society

The FREE Renal Cell Cancer Patient Toolkit CD-ROM includes the Managing Your Therapy for Renal Cell Cancer Patient Guide (PDF) and presentation slides and appendices from the July 14, 2007 breakfast symposium held during the Oncology Nursing Society's (ONS) 2007 Mentorship Weekend.

Please click here to order the free CD-ROM. Optionally, see below to download the files individually.

• Managing Your Therapy for RCC Patient Guide
• Presentation Sides
• Appendices